SCHEMBL10766856

SCHEMBL10766856

[CH2]CC(=O)CC=C

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL101280 0.83
Phosphine SCHEMBL28626874 0.80
SCHEMBL28491261 0.80
Charcoal, Activated SCHEMBL7916448 0.80
SCHEMBL11973891 0.78 ALDH1A1 (0.35)
SCHEMBL3627376 0.78 ALDH1A1 (0.35)
Ethyne SCHEMBL7258726 0.78 TSHR (0.33)
SCHEMBL8807181 0.75
Benzene SCHEMBL6429767 0.75 LMNA (0.37)
SCHEMBL11025503 0.75

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0133098-B1 SYNERGISTIN DERIVATIVES AND THEIR PREPARATION RHONE-POULENC SANTE (FR) 1987-01-14 EP claimed
EP-0005610-B1 1-(HETEROCYCLYLALKYL)-1,3-DIHYDRO-2H-BENZIMIDAZOL-2-ONES, THEIR PREPARATION, THEIR PHARMACEUTICAL COMPOSITIONS AND THEIR USE AS BETA-ADRENERGIC RECEPTOR BLOCKERS JANSSEN PHARMACEUTICA N.V. (BE) 1982-12-15 EP disclosed
US-4181802-A ADRENERGIC BLOCKING AGENTS JANSSEN PHARMACEUTICA N.V. (BE) 1980-01-01 US disclosed
EP-0005610-A2 1-(Heterocyclylalkyl)-1,3-dihydro-2H-benzimidazol-2-ones, their preparation, their pharmaceutical compositions and their use as beta-adrenergic receptor blockers JANSSEN PHARMACEUTICA N.V. (BE) 1979-11-28 EP disclosed